Fourth Nationwide Serosurvey by Indian Council of Medical Analysis (ICMR) Indicates that more than two-thirds of India’s population has developed antibodies against COVID-19.
The findings of the survey, performed between June and July of 2021, confirmed 67.6 % of the nation’s 1.3 billion folks offered with antibodies. This displays a considerable improve from the third serosurvey performed between December 2020 and January 2021, estimated to be 24.1 %.
highest prevalence of antibodies In the 45-60 age demographic, it was found at 77.6 percent, followed by those over the age of sixty, at 76.7 percent. Amongst these aged eighteen to 44, the prevalence was 66 %. Prevalence in city areas is 69.6 % – 3.1 % greater than in rural areas. Of the taking part girls, 69.2 % offered with antibodies versus 65.8 % of the lads.
Dr. Bharam Bhargava, Director Common, ICMR Welcoming the news, but urged for constant vigilance. “The findings clearly present that there’s a ray of hope, however there isn’t any room for complacency,” he mentioned, noting that 400 million Indians exist with out antibodies and are due to this fact prone to contracting the virus. It is usually price noting that an infection with COVID-19 remains to be potential even when one has been absolutely vaccinated or has beforehand contracted the novel coronavirus.
Components contributing to the substantial improve could embody the excessive variety of infections the nation noticed throughout second wave and the launch of the nation’s vaccination marketing campaign. Nonetheless, it’s price noting that of these surveyed, 62.2 per cent had been partially vaccinated up to now and solely 13 per cent had been absolutely vaccinated – Underscoring concerns over a vaccine rollout described by some commentators as “lagging”. One serosurve discovering was that one in ten healthcare employees had not been vaccinated, though the group had a wholesome seropositivity of 85.2 %.
Latest analysis discovered that antibodies from an infection with COVID-19 can final for a minimum of 9 months in most individuals who contract the virus. Researchers in Italy tested 85 percent of the 3,000 residents of the city of Vo and found that 98.8 percent of those infected in the first wave still presented with antibodies nine months later.. There was no distinction between these with asymptomatic or symptomatic infections.